Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Ashland
ASH
$3.32B
| $1.5M | ﹤0.01% |
19,610
+8,703
| +80% | +$661K |
|
3252
South Plains Financial
SPFI
$849M
| $1.5M | ﹤0.01% |
71,891
+7,737
| +12% | +$140K |
|
|
ARQL
3253
CALL
DELISTED
Arqule Inc
ARQL
| $1.5M | ﹤0.01% |
+75,000
| New | +$870K |
|
3254
Lantheus
LNTH
$6.6B
| $1.5M | ﹤0.01% |
72,887
+13,877
| +24% | +$281K |
|
|
SAFE
3255
Safehold
SAFE
$1.13B
| $1.5M | ﹤0.01% |
21,156
+6,414
| +44% | +$406K |
|
3256
Artivion
AORT
$1.29B
| $1.49M | ﹤0.01% |
55,177
+13,064
| +31% | +$321K |
|
3257
Stewart Information Services
STC
$2.09B
| $1.49M | ﹤0.01% |
36,604
-171
| -0.5% | -$7.01K |
|
3258
PUT
Cal-Maine
CALM
$3.98B
| $1.49M | ﹤0.01% |
34,900
-21,300
| -38% | -$887K |
|
3259
Standex International
SXI
$4.09B
| $1.49M | ﹤0.01% |
18,789
+4,231
| +29% | +$322K |
|
|
BNFT
3260
DELISTED
Benefitfocus, Inc.
BNFT
| $1.49M | ﹤0.01% |
67,802
+45,441
| +203% | +$1.03M |
|
3261
CALL
Coeur Mining
CDE
$16.1B
| $1.49M | ﹤0.01% |
183,900
+69,800
| +61% | +$430K |
|
3262
PUT
iShares MSCI Turkey ETF
TUR
$213M
| $1.49M | ﹤0.01% |
54,800
-2,200
| -4% | -$56.8K |
|
3263
CTS Corp
CTS
$1.89B
| $1.48M | ﹤0.01% |
49,350
-2,846
| -5% | -$82.5K |
|
|
LMNX
3264
DELISTED
Luminex Corp
LMNX
| $1.48M | ﹤0.01% |
63,780
+10,652
| +20% | +$220K |
|
3265
CALL
Consolidated Edison
ED
$40.2B
| $1.48M | ﹤0.01% |
16,300
+9,400
| +136% | +$842K |
|
3266
PUT
Tapestry
TPR
$32.7B
| $1.48M | ﹤0.01% |
54,700
-24,100
| -31% | -$628K |
|
3267
Vanda Pharmaceuticals
VNDA
$309M
| $1.47M | ﹤0.01% |
89,791
+14,215
| +19% | +$215K |
|
3268
ProShares UltraPro S&P 500
UPRO
$5.6B
| $1.47M | ﹤0.01% |
42,056
+24,600
| +141% | +$753K |
|
3269
CALL
Ventas
VTR
$47.3B
| $1.47M | ﹤0.01% |
25,500
-11,800
| -32% | -$741K |
|
|
IMGN
3270
DELISTED
Immunogen Inc
IMGN
| $1.47M | ﹤0.01% |
287,984
+35,138
| +14% | +$119K |
|
3271
Unisys
UIS
$210M
| $1.47M | ﹤0.01% |
123,864
+10,275
| +9% | +$103K |
|
|
TCDA
3272
DELISTED
Tricida, Inc. Common Stock
TCDA
| $1.47M | ﹤0.01% |
38,823
+17,536
| +82% | +$654K |
|
3273
CALL
Diageo
DEO
$51.6B
| $1.47M | ﹤0.01% |
8,700
-600
| -6% | -$97.5K |
|
|
NBLX
3274
DELISTED
Noble Midstream Partners LP
NBLX
| $1.47M | ﹤0.01% |
55,162
-36,168
| -40% | -$856K |
|
3275
PUT
Aptiv
APTV
$9.61B
| $1.46M | ﹤0.01% |
15,400
-6,100
| -28% | -$559K |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.